133 related articles for article (PubMed ID: 26250343)
1. SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis.
Zhou PR; Xu XJ; Zhang ZL; Liao EY; Chen DC; Liu J; Wu W; Jiang Y; Wang O; Xia WB; Xing XP; Xu L; Li M
Pharmacogenomics; 2015; 16(10):1077-88. PubMed ID: 26250343
[TBL] [Abstract][Full Text] [Related]
2. LRP5 polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.
Zhou PR; Liu HJ; Liao EY; Zhang ZL; Chen DC; Liu J; Wu W; Xing XP; Xia WB; Xu L; Li M
Pharmacogenomics; 2014 Apr; 15(6):821-31. PubMed ID: 24897288
[TBL] [Abstract][Full Text] [Related]
3. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
4. Associations of polymorphisms in the SOST gene and bone mineral density in postmenopausal Chinese Women.
Zhang H; He JW; Wang C; Zhang Z; Yue H; Hu WW; Gu JM; Hu YQ; Li M; Fu WZ; Zhang ZL
Osteoporos Int; 2014 Dec; 25(12):2797-803. PubMed ID: 25103216
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.
Wang C; Zheng H; He JW; Zhang H; Yue H; Hu WW; Gu JM; Shao C; Fu WZ; Hu YQ; Li M; Liu YJ; Zhang ZL
Pharmacogenomics J; 2015 Apr; 15(2):158-64. PubMed ID: 25223561
[TBL] [Abstract][Full Text] [Related]
6. Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.
Wang WJ; Fu WZ; He JW; Wang C; Zhang ZL
Pharmacogenomics J; 2019 Oct; 19(5):490-498. PubMed ID: 30287911
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in sclerostin, dickkopfs and secreted frizzled-related protein genes and bone mineral density in postmenopausal Korean women.
Lee DO; Kim H; Ku SY; Kim SH; Kim JG
Gynecol Obstet Invest; 2014; 77(3):186-93. PubMed ID: 24662300
[TBL] [Abstract][Full Text] [Related]
8. Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.
Liu Y; Liu H; Li M; Zhou P; Xing X; Xia W; Zhang Z; Liao E; Chen D; Liu J; Tao T; Wu W; Xu L
Chin Med J (Engl); 2014; 127(4):662-8. PubMed ID: 24534219
[TBL] [Abstract][Full Text] [Related]
9. OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia.
Zheng H; Wang C; He JW; Fu WZ; Zhang ZL
Pharmacogenet Genomics; 2016 Jan; 26(1):12-9. PubMed ID: 26426211
[TBL] [Abstract][Full Text] [Related]
10. Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women.
Velázquez-Cruz R; Jiménez-Ortega RF; Parra-Torres AY; Castillejos-López M; Patiño N; Quiterio M; Villarreal-Molina T; Salmerón J
BMC Musculoskelet Disord; 2014 Nov; 15():400. PubMed ID: 25430630
[TBL] [Abstract][Full Text] [Related]
11. The analysis of DKK1 polymorphisms in relation to skeletal phenotypes and bone response to alendronate treatment in Chinese postmenopausal women.
Wang JY; Zhou PR; Liu Y; Xu XJ; Ma DD; Xia WB; Jiang Y; Wang O; Xing XP; Li M
Pharmacogenomics; 2016 Feb; 17(3):209-17. PubMed ID: 26780085
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites.
Uitterlinden AG; Arp PP; Paeper BW; Charmley P; Proll S; Rivadeneira F; Fang Y; van Meurs JB; Britschgi TB; Latham JA; Schatzman RC; Pols HA; Brunkow ME
Am J Hum Genet; 2004 Dec; 75(6):1032-45. PubMed ID: 15514891
[TBL] [Abstract][Full Text] [Related]
13. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the clinical effects between Dihuang Decoction and alendronate sodium in the treatment of primary osteoporosis].
Wan JM; Zhang JF; Huang K; Zhang PL; Zhu SY
Zhongguo Gu Shang; 2019 Jun; 32(6):535-538. PubMed ID: 31277537
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
Iwamoto J; Takeda T; Sato Y; Uzawa M
Clin Rheumatol; 2007 Feb; 26(2):161-7. PubMed ID: 16565894
[TBL] [Abstract][Full Text] [Related]
16. Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study.
Hejdova M; Palicka V; Kucera Z; Vlcek J
Pharm World Sci; 2005 Jun; 27(3):149-53. PubMed ID: 16096879
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of early-stage bi-weekly alendronate to improve bone mineral density and bone turnover in chinese post-menopausal women at risk of osteoporosis.
You L; Sheng ZY; Chen JY; Pan L; Chen L
J Int Med Res; 2011; 39(1):302-10. PubMed ID: 21672334
[TBL] [Abstract][Full Text] [Related]
18. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
19. Association Between Geranylgeranyl Pyrophosphate Synthase Gene Polymorphisms and Bone Phenotypes and Response to Alendronate Treatment in Chinese Osteoporotic Women.
Han LW; Ma DD; Xu XJ; Lü F; Liu Y; Xia WB; Jiang Y; Wang O; Xing XP; Li M
Chin Med Sci J; 2016 Mar; 31(1):8-16. PubMed ID: 28031082
[TBL] [Abstract][Full Text] [Related]
20. Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis.
Gallagher JC; Rosen CJ; Chen P; Misurski DA; Marcus R
Bone; 2006 Dec; 39(6):1268-75. PubMed ID: 16884968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
